Actionable insights straight to your inbox

Equities logo

AP FACT CHECK: Trump Falsely Claimed FDA Had Approved Coronavirus Drug

FDA Commissioner Dr. Stephen Hahn emphasized that chloroquine still requires testing to determine if it can help patients with COVID-19.
The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Our teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. We provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands.
The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Our teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. We provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands.

Image: FDA Commissioner Stephen M. Hahn, MD; US President Donald J. Trump

WASHINGTON (AP) — President Donald Trump misstated the facts Thursday when he asserted that the Food and Drug Administration (FDA) had just approved a decades-old malaria drug to treat patients infected by the coronavirus.

After his FDA chief clarified that the drug still needs testing, Trump went on to overstate the drug’s potential upside in helping contain the outbreak.

A look at his claims at a news briefing:

TRUMP:

“And we’re going to be able to make that drug available almost immediately, and that’s where the FDA has been so great. They — they’ve gone through the approval process. It’s been approved.”

THE FACTS:

The drug, known chemically as chloroquine, has been available for decades to treat the mosquito-borne illness malaria. Technically, doctors can already prescribe the drug to patients with COVID-19, a practice known as off-label prescribing. Trump falsely suggested to reporters, however, that the FDA had just cleared the drug specifically for the viral pandemic spreading in communities across the U.S. That would mean that the drug had met the FDA’s standards for safety and effectiveness.

Minutes later, FDA Commissioner Dr. Stephen Hahn emphasized that the drug still needs testing to determine if it can help patients. He said chloroquine would have to be tested in “a large pragmatic clinical trial to actually gather that information.”

Drug trials typically require hundreds or thousands of patients and, even when accelerated, take weeks or months to complete. In his remarks, Hahn reflected on his background as a cancer doctor and warned against giving patients “false hope” before drugs are fully vetted.

While chloroquine has shown promise in preliminary laboratory studies, some experts are skeptical it will prove effective in human testing.

“I think it could be a game changer, and maybe not,” Trump said, discussing the drug.

But the FDA reiterated in a statement Thursday that there are “no FDA-approved therapeutics or drugs to treat, cure or prevent COVID-19.”

___

TRUMP:

Referring to the growing numbers of infected patients, Trump said, “If chloroquine or hydroxychloroquine works, or any of the other things that they’re looking at that are not quite as far out … your numbers are going to come down very rapidly.”

THE FACTS:

The drugs to which he is referring are for treatment in patients who are already infected. These drugs do not prevent spread of the virus. One study is testing chloroquine to try to protect health care workers at highest risk of infection, because a vaccine is likely a year or more away.

___

AP Chief Medical Writer Marilynn Marchione contributed to this report.

_____

AP Fact Check is a series that looks at the veracity of claims by political figures.

_____

Source: AP News

A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.